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INTRODUCTION
             Deficient or excessive levels of minerals can be an adverse factor in human and animal 
pregnancies, which for a long time have been correlated with many maternal complications. 
Minerals like zinc, copper and calcium have been documented to play an important role in 
pregnancy and fetal outcomes.
Trace  elements  like  zinc  and  copper  are  essential  for  the  normal  growth  and 
development;  they  have  been  implicated  in  various  reproductive  events  like  preeclampsia, 
infertility, pregnancy wastage, congenital anomalies, placental abruption, premature rupture of 
membranes,  neurological  abnormalities,  fetal  deaths  and low birth  weights.  Calcium is  the 
macronutrient that has been best studied in relationship to preeclampsia.
          Preeclampsia is a critically important disease of pregnancy, one of the major causes of 
fetal and maternal morbidity and mortality throughout the world. It is diagnosed by new onset 
of increased blood pressure, proteinuria occurring after 20 weeks of gestation and remission of 
these signs after delivery.
           Preeclampsia is associated with substantial risks. For the fetus these include intra-uterine 
growth  retardation,  death  and  prematurity  whereas  the  mother  is  at  risk  for  seizures 
(eclampsia), renal failure, pulmonary edema, stroke and death. Despite considerable research, 
the cause or causes of preeclampsia remain unclear and there are no clinically useful screening 
tests to identify women in whom it will develop. The cause of preeclampsia is multifactorial 
and involves both genetic and other factors.
The role of various minerals like zinc, copper and calcium in relation to preeclampsia 
have been studied in different populations, all over the world. There are many studies showing 
a lowering of serum zinc along with the rise in serum copper and ceruloplasmin levels. Low 
serum  calcium  levels  have  often  been  associated  with  preeclampsia.  Several  calcium 
supplementation trials have shown that the incidence of preeclampsia can also be reduced by 
increasing the calcium intake.
          Hence the interest has developed to assess the above minerals in preeclampsia, in our 
population. Therefore the present study has been undertaken with the view of establishing the 
role  of  zinc,  copper  and calcium in  preeclampsia  by  determining  their  levels  in  serum in 
nonpregnant, normal pregnant and preeclamptic women. 
REVIEW OF LITERATURE
Preeclampsia is a pregnancy specific disorder characterized by high blood 
pressure, headache, protein in urine and edema of the face, hands and feet. It can 
progress to eclampsia,  which is  marked by convulsions and can lead to coma, 
brain damage and death. More recently, increased attention to the multisystemic 
nature  of  the  syndrome  with  involvement  of  almost  all  organs,  activation  of 
coagulation cascade and increased sensitivity to pressor agents has expanded the 
understanding of  the  disorder.1   Preeclampsia  has  been dubbed the  "disease  of 
theories" because of the multiple hypotheses proposed to explain its occurrence.2
CLASSIFICATION OF HYPERTENSIVE DISORDERS COMPLICATING 
PREGNANCY
There  as  5  types  of  hypertensive  diseases  in  pregnancy.  The  diagnostic 
criteria  of  each  group  based  on National  high  blood  pressure  education 
programme working group report3 is elaborated below
1.  Gestational Hypertension (formerly pregnancy induced hypertension (or) 
                                                  Transient hypertension)
• BP ≥ 140/90 mmHg for first time during pregnancy
• No proteinuria
• BP return to normal < 12 weeks’ postpartum
• Final diagnosis made only during  postpartum period
• May  have  other  signs  of  preeclampsia,  for  example,  epigastric 
discomfort or thrombocytopenia.
2. Preeclampsia (gestational hypertension plus proteinuria)
Minimum Criteria
• BP ≥ 140/90 mmHg after 20 weeks’ gestation 
• Proteinuria ≥ 300mg / 24 hours or ≥ 1 + dipstick
Increased certainty of preeclampsia
• BP ≥ 160/110 mmHg.
• Proteinuria 2.0 g/24 hours or  ≥ 2 + dipstick.
• Serum creatinine > 1.2 mg/dl unless known to be previously elevated.
• Platelets < 100,000/mm3.
• Microangiopathic hemolysis (increased LDH).
• Elevated ALT or AST.
• Persistent headache or other cerebral or visual disturbance.
• Persistent epigastric pain.
3. Eclampsia
Seizures  that  cannot  be  attributed   to  other  causes  in  a  women  with 
preeclampsia.
4. Superimposed Preeclampsia (on chronic hypertension)
1. New-onset proteinuria ≥ 300mg/24 hours in hypertensive women but 
no proteinuria before 20 weeks’ gestation.
2. A sudden increase in proteinuria or blood pressure, or platelet count 
< 100,000/mm3, in women with hypertension and proteinuria before 
20 weeks’ gestation.
5. Chronic hypertension
BP  ≥ 140/90  mmHg  before  pregnancy or  diagnosed before  20  weeks’ 
gestation.
(or)
Hypertension first diagnosed after 20 weeks’ gestation and persistent after 
12 weeks’ postpartum.
CURRENT CONCEPTS OF PATHOGENESIS OF PREECLAMPSIA
Preeclampsia is characterized by a generalized dysfunction of the maternal 
endothelium and impairment of endothelium - dependent relaxation in maternal 
resistance arteries. The placenta appears to be the pregnancy component that leads 
to  the  disorder.  Fetus  is  not  the  contributor.  Important  placental  feature  in 
preeclampsia is poor perfusion.4
Role of placenta in preeclampsia
Evidence points to the placenta as the key source of factors that lead to the 
maternal  endothelial  cell  dysfunction  in  preeclampsia.5 The  genesis  of 
preeclampsia  is  clearly  related  to  deficient  trophoblast  invasion  and  failure  of 
uterine  artery  remodeling.6 This   defective  spiral  artery  remodeling  results  in 
reduced  uteroplacental  perfusion  and  foci  of  placental  hypoxia  or  ischemia. 
Placental infarcts occur with increased frequency in preeclampsia, which results in 
the excess production of placental tumor necrosis factor-α (TNF-α).7 Increased 
production  of  TNF-α  from the  placenta  and/or  maternal  adipose  tissue  could 
contribute to insulin resistance, dyslipidemia and oxidative stress in preeclampsia. 
Lipid peroxidation products namely malondialdehyde and 4 hydroxy nonenal are 
increased  due  to  placental  oxidative  stress  leading  to  increase  in 
syncytiotrophoblast  membrane shedding into the maternal  circulation.  Placental 
lipid peroxidation products, TNFα and syncytiotrophoblast membrane fragments 
are  candidate  blood  borne  agents  with  the  potential  to  cause  endothelial  cell 
dysfunction.
Current thinking characterizes preeclampsia into two stages.8 
Stage -1 : Reduction in perfusion
Stage - 2 : Maternal syndrome
Reduced  perfusion  of  almost  all  the  organs  is  due  to  vasoconstriction,  micro 
thrombi  formation and reduced circulatory  plasma volume.  Vasoconstriction  is 
secondary to an increased sensitivity of the vasculature to any pressor agent (ex 
Angiotensin  II).  Normal  pregnant  women  develop  refractoriness  to  infused 
vasopressors.  Activation  of  coagulation  cascade  produces  microthrombi.The 
reduced plasma volume,  reflecting an endothelial  leak with fluid loss from the 
intravascular compartment, further compromises perfusion.
Oxidative  stress  is  proposed  as  the  linkage  of  the  two  stages  of 
preeclampsia.9 It is posited that reduced placental perfusion generates free radicals 
which in the appropriate maternal environment generate systemic oxidative stress. 
This hypothesis is supported by the evidence of oxidative stress in the circulation 
and tissues of women with preeclampsia.10
Endothelial cell dysfunction in preeclampsia
Preeclampsia is characterized by a generalized dysfunction of the maternal 
endothelium, as demonstrated by increased levels of factors VIII, total and cellular 
fibronectin, thrombomodulin, endothelin, growth factor activity, and a disturbance 
of the prostacyclin / thromboxane A2 balance.11  There are also increased levels of 
VCAM-1 (Vascular  Cell  Adhesion  Molecule).12Evidences  indicate  that  adverse 
changes in structure and function of the maternal vascular endothelium account for 
the  altered  vascular  reactivity,  activation  of  the  coagulation  cascade  and  the 
multisystem  damage  that  occurs  in  preeclampsia.  Maternal  endothelial  cell 
dysfunction  is  the  key  event  resulting  in  diverse  clinical  manifestations  of 
preeclampsia.
MATERNAL CONSEQUENCES
In preeclampsia, cardiovascular changes are basically related to increased 
cardiac  afterload  caused  by  hypertension.  Maternal  thrombocytopenia  can  be 
induced by preeclampsia - eclampsia. The cause of thrombocytopenia results from 
platelet activation and consumption. Plasma levels of renin, angiotensin II and 
aldosterone are  increased during normal  pregnancy.  In  preeclampsia  there  is  a 
decrease of these values towards the normal non-pregnant range. There is extra 
cellular fluid volume expansion manifesting as edema. There is  no appreciable 
change in the electrolyte values.
There should be some degree of proteinuria to establish the diagnosis of 
preeclampsia.  This  is  due  to  increased  permeability  to  large  molecular  weight 
proteins like hemoglobin, globulins and transferrin, along with albumin.
With severe preeclampsia, at times there are alterations in tests of hepatic 
function like  delayed excretion of  bromosulfophthalein and elevation of  serum 
aspartate  amino-transferase  levels.  Hyperbilirubinemia  is  uncommon.  Liver 
involvement is frequently accompanied by other organ involvements resulting in 
HELLP syndrome (Hemolysis, Elevated liver enzymes and Low platelets).
Retinal artery vasospasm may be associated with visual disturbances, but 
blindness  is  uncommon.  Symptoms of  cerebral  edema are  lethargy,  confusion, 
blurred vision and coma.
CAUSES OF PREECLAMPSIA
          Among  the  many  proposed  causes  are  increased  oxidative  stress, 
dyslipidemia,  inflammatory  factors,  increased  insulin  resistance,  prostaglandin 
imbalance  (Increased  ratio  of  thromboxane  levels  to  prostacyclin  levels), 
immunologic derangements (a maternal immune reaction to paternal antigen in the 
placenta),  genetic  factors  and  nitric  oxide.  Thus  preeclampsia  is  likely  to  be 
multifactorial  in  origin and characteristics  of  the  mother  and the  placenta  may 
interact to lead to its development.
Oxidative stress
In normal pregnancy free radical activity is increased either by increased 
cell  turnover,  increased  cell  damage  or  a  decline  in  antioxidant  free  radical 
scavenging mechanisms.13 There  is  increased  attention  for  the  hypothesis  that 
placental  and  maternal  free  radical  reactions  promote  a  cycle  of  events  that 
compromise  the  defensive  functioning  of  the  vascular  endothelium,  in 
preeclampsia. 
Thus oxidative stress may be the point at which multiple factors converge 
resulting in endothelial cell dysfunction and the consequent clinical manifestations 
of preeclampsia. As in atherosclerosis, in preeclampsia also the endothelial cells 
are important targets and the dyslipidemia predisposing to atherosclerosis, occurs 
in  preeclamptic  pregnancies.  Oxidative  stress  interacting  with the  dyslipidemia 
(formation of lipid peroxidation products) has been hypothesized to be important 
in  the  altered  endothelial  function  that  results  in  the  clinical  manifestations. 
Women  with  preeclampsia  have  increased  triacylglycerols,  increased  LDL, 
increased LDL cholesterol and reduced HDL cholesterol.14
Inflammatory factors 
Although  the  pathophysiology  of  preeclampsia  is  not  understood 
completely,  there  is  an  interest  in  a  possible  link  between  inflammation  and 
preeclampsia. Preeclampsia can result when there is a generalized perturbation of 
the  normal,  generalized  maternal  intravascular  inflammatory  adaptation  to 
pregnancy.15
The maternal syndrome of preeclampsia has previously been ascribed to 
generalised maternal endothelial cell dysfunction. Redman et al15 have suggested 
that  the  endothelial  dysfunction  is   part  of  a  more  generalized  intravascular 
inflammatory reaction involving intravascular leukocytes as well as the clotting 
and complement systems. They also suggest that such an inflammatory response is 
already  well  developed  in  normal  pregnancy  and  hence  they  argue  that 
preeclampsia  arises  when  a  universal  maternal  intravascular  inflammatory 
response to pregnancy is too strong or if the stimulus is too strong to induce such a 
response.  Normal  pregnancy  is  associated  with  activation  of  peripheral  blood 
leukocytes, a response more marked in women with preeclampsia.16 Before going 
into  the  details  of  this  inflammatory  state  in  preeclampsia,  the  acute  phase 
response can be discussed as follows.
Acute phase response
The  "acute  phase  response”  is  a  prominent  systemic  reaction  of  the 
organism to local or systemic disturbances in its homeostasis caused by infection, 
tissue injury, trauma or surgery, neoplastic growth or immunologic disorders.17
Local inflammation is the major reaction of the body upon tissue injury. At 
the site of tissue damage, a number of responses of the tissue itself are initiated. 
Proinflammatory  cytokines  are  released,  and  the  vascular  system  and 
inflammatory cells are activated.18 These responses lead to the production of more 
cytokines and other inflammatory mediators which circulate in the blood resulting 
in a systemic acute phase reaction with the following laboratory findings.
1. Increased  values  of  adrenocorticotrophic  hormone  (ACTH)  and 
glucocorticoids.
2. Activation of the complement system and blood coagulation system.
3. Decreased  levels  of  calcium,  zinc,  iron,  vitamin  A  and  α - 
tocopherol.
4. Change in concentration of several plasma proteins, the acute phase 
proteins (APP), largely due to a changed hepatic metabolism19.
Cytokines and acute phase response
At least 15 different low molecular weight peptide mediators are known to 
be secreted by activated leukocytes (Interleukins) and other cells. They are 
collectively termed cytokines and are involved in triggering the acute phase 
response. For ex   TNFα, IL - 1 & IL 6.
The  next  important  aspect  of  the  acute  phase  response  is  the  altered 
biosynthetic profile of the liver. Liver synthesizes a characteristic range of plasma 
proteins called the acute phase proteins (or) acute phase reactants, following an 
inflammatory stimulus. In this hepatic acute phase response, TNFα , IL-1 and IL-6 
play  a  key  role.20 The  above  cytokines  activate  hepatocytic  receptors  and  the 
synthesis of various acute phase proteins starts. IL-6 is the major mediator for the 
hepatic secretion of most of the acute phase proteins.21  IL-6 stimulates the liver to 
produce acute phase proteins, stimulates the proliferation of B lymphocytes and 
increases neutrophil production. TNF-  α is the principle cytokine that mediates 
acute inflammation.
Other  effects  of  the  acute  phase  response  include  induction  of  the 
metallothionein synthesis22 leading to decreased serum zinc levels. Calcium levels 
are also reduced.23 Hence these are also included under acute phase reactants.
Acute phase reactants17, 23
Positive acute phase reactants
1. Major  acute  phase  reactants  -  serum amyloid  A and  P  components,  C- 
reactive protein.
2. Ceruloplasmin, complement factor -3
3. Haptoglobin,  fibrinogen,  α globulins  with  antiprotease  -  activity  and 
lipopolysaccharide binding protein.
Negative acute phase reactants
1. Transthyretin, Retinol binding protein.
2. Albumin and Transferrin
3. Serum zinc, iron and calcium
Acute phase response in preeclampsia
Redman  et  al15 have  suggested  that  preeclampsia  is  attributable  to  an 
excessive  maternal  inflammatory  response  to  pregnancy  secondary  to  a 
combination of placental and maternal factors related to phenotype and genotype. 
Inflammatory  cells  are  activated  in  preeclampsia  and  localized  to  the  site  of 
vascular  injury.  This  white  cell  activation  is  associated  with  higher  levels  of 
proinflammatory markers like cytokines.24 This inflammatory response contributes 
to the wider syndrome of endothelial dysfunction and thrombotic and metabolic 
disturbances  seen  in  preeclampsia.25 Recent  studies  have  demonstrated  that 
cytokines  -  mediators  of  inflammatory  response  may  cause  endothelial 
dysfunction through different mechanisms such as oxidative stress and endothelial 
cell  damage.26 Dilys J Freeman et al25 and   many others24,27,28,29 have observed 
TNF-α and IL-6 levels to be higher in preeclamptic women.
Endothelial cells have been demonstrated to have increased IL-6 production 
in  severe  preeclampsia.30  The  elevation  of  IL-6  levels  may  indicate  a  greater 
degree of endothelial dysfunction.
As we have already seen, increase in IL-6 levels results in increased hepatic 
synthesis  of  the  acute  phase  proteins,  as  part  of  the  acute  phase  response. 
According to  Vince GS et  al29 increases in  plasma ceruloplasmin,  complement 
activity, α1 antitrypsin and haptoglobin and reduction in albumin and transferrin in 
preeclampsia are characteristic of the acute phase reaction that may be related to 
increase in IL-6 levels.
Hence  the  inflammatory  response  in  preeclampsia  may  be  denoted  as 
excessive acute phase response.
Role of other factors
Hyperinsulinemia and increased insulin resistance are seen in preeclamptic 
women. Carl A hubel31 has stated that TNF-α contributes to the development of 
insulin resistance. Thromboxanes are increased and prostacyclin and prostaglandin 
E2 are decreased resulting in vasoconstriction and increased sensitivity to pressor 
agents.
The  tendency  for  preeclampsia  is  inherited.  The  susceptibility  to 
preeclampsia is dependent upon a single recessive gene. There is an association 
between the histocompatibility antigen HLA-DR4 and proteinuric hypertension. 
Nitric oxide (NO) is a potent vasodilator. It has been proposed that deficient nitric 
oxide  production  or  availability  may  contribute  to  the  patho  physiology  of 
preeclampsia.
             The risk of hypertensive disorders due to pregnancy is enhanced in 
circumstances where formation of blocking antibodies to antigenic sites  on the 
placenta might be impaired. In preeclamptic women, there are lower levels of T-
helper cells compared with normotensive women.               
The pathophysiology of preeclampsia has been illustrated below as a chart.
Maternal 
vascular disease
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Excessive 
trophoblast
Genetic ,immunologic or 
inflammmatory factors
Vasoactive agents:
Prostaglandins, 
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Endothelins
Reduced uteroplacental perfusion
ENDOTHELIAL 
ACTIVATION
Noxious agents:
Cytokines
Lipid peroxidases
Vasospasm
m
Capillary 
leak
Thrombocyto
penia
Edema
Proteinuria
Hemoconcentration
Activation 
of 
coagulation
Hypertension
Seizures
Oliguria
Abruption
Liver ischemia
PATHOPHYSIOLOGY OF PREECLAMPSIA
MINERAL INVOLVEMENT IN PREECLAMPSIA
The epidemiological and biological evidence suggest that minerals play an 
important role in maternal and fetal outcomes. Various minerals like zinc, copper, 
calcium and magnesium have been implicated in preeclampsia. There are many 
studies showing a decrease in the levels of zinc and calcium; increase in the levels 
of copper and either an increase or decrease in the levels of magnesium, in the 
serum of preeclamptic women. 
As the study has been restricted to the former three minerals a review of 
them follows.
ZINC
Zinc is an important element performing a range of functions in the body, 
as it is a cofactor for the synthesis of a number of enzymes, DNA and RNA. Zinc 
is an integral component of nearly 300 enzymes in different species. Important 
zinc  containing  enzymes  are  carbonic  anhydrase,  alkaline  phosphatase,  RNA 
polymerase, DNA polymerase, thymidine kinase, carboxypeptidases and alcohol 
dehydrogenase.
Approximately  20-30% of  ingested dietary  zinc  is  absorbed.  Absorption 
occurs  mostly  in  the  duodenum and  proximal  jejunum.  The  absorbed  zinc  is 
transported  in  blood  plasma  by  albumin  (60-70%)  and  by  α2-macroglobulin 
(30-40%).  A small  amount is  associated with transferrin and free amino acids. 
Major route of zinc excretion is via the faeces. Urinary losses of zinc are about 
0.6mg/day in an adult consuming about 2mg/day of zinc.
The  additional  need  for  zinc  in  human  pregnancy  is  estimated  to  be 
approximately 100mg.32 This represents approximately 5-7% of the whole body 
zinc concentration in a non-pregnant woman. The additional need for zinc during 
pregnancy can be met either by an increase in zinc intake or by adjustments in zinc 
homeostasis. Intestinal zinc absorption appears to be the primary means by which 
zinc retention is increased to meet the fetal demands.       
Other mechanisms for adjustment of zinc metabolism include reduced 
endogenous  gastrointestinal  zinc  excretion,  renal  conservation  and  release  of 
maternal tissue zinc. The  concentration  of  urinary  zinc  increases  during 
gestation, reaching a value nearly twice that of preconception. This is possibly 
because of an increase in glomerular filtration rate. Hence renal conservation does 
not appear to be a mechanism for retaining zinc during pregnancy and lactation.
The demand for zinc to support fetal growth may also be met by the release 
of maternal tissue zinc, as is observed in some experimental animals. However in 
humans, there is not much evidence to prove the release of maternal tissue zinc 
during pregnancy. Hence it  appears that adjustments in zinc absorption are the 
primary means by which additional zinc needs are met during pregnancy. 
Normal serum level of zinc = 0.7 – 1.2 mg/L 
MODEL OF ZINC METABOLISM IN LATE PREGNANCY
                        Rapidly exchanging tissue zinc – liver
                        Slowly exchanging tissue zinc – muscle
SERUM ZINC IN PREGNANCY
Zinc is 60-85% bound to albumin and low levels of plasma zinc have been 
reported to occur when serum albumin is lowered. Giroux et al33 showed that 75% 
of the decrease in total serum zinc in pregnancy was due to a decrease in albumin 
bound to zinc and postulated that hypozincemia of pregnancy was secondary to the 
hypoalbuminemia.   They also suggested that  there was a decreased affinity  of 
albumin for zinc.
Sheena  tuttle  et  al34 have  said  that  the  apparent  hypozincemia  and 
hypoalbuminemia  of  normal  pregnancy  are  largely  due  to  increasing  plasma 
volume after the first trimester. Christine et al35 in their study have suggested that 
the decrease in serum zinc in the late gestation could reflect maternal fetal zinc 
transfer  in  response  to  fetal  growth.  The  decline  represents  a  physiological 
adaptation  to  pregnancy  reflecting  in  part,  maternal  fetal  transfer  of  zinc  and 
expansion of maternal plasma volume.
Janette  Taper  et  al36  have  suggested  that  blood  volume  expansion  in 
pregnant women contributed to a greater diluting effect on serum zinc and the 
decrease could also be attributed to increased levels of estrogen.  Isabelle et al37 
have said that severely depressed levels of zinc in serum indicate inadequate zinc 
status in pregnancy.
Pathak  Priyali  &  Kapil  Umesh38  in  their  study  have  stated  that  during 
pregnancy there  is  a  decrease  in  circulating zinc  and also a  decline  occurs  as 
pregnancy  progresses  possibly  due  to  decrease  in  zinc  binding  and  increased 
transfer of zinc from mother to the fetus. Tamura et al39 have stated that the decline 
in  serum zinc  concentration  during  pregnancy  has  been  well  documented  and 
could be due to a normal physiologic adjustment to pregnancy, a  response to 
hormonal changes, hemodilution or a combination of these.
Conditions that may induce a secondary zinc deficiency during pregnancy40
• Factors that may limit the net absorption of zinc
- High intake of dietary inhibitors of zinc absorption, such as phytate, 
liver and calcium.
- High doses of supplemental iron 
- Gastrointestinal diseases that limit zinc absorption such as intestinal 
bypass,  crohn's  disease,  bacterial  overload,  and  viral  or  bacterial 
infections.
• Factors that may interfere with placental transport of zinc are
- Cigarette smoking
- Alcohol abuse
- Acute maternal infections
- Strenuous exercise
- Therapy with certain drugs
Zinc deficiency in India
In  India  there  is  occurrence  of  milder  grades  of  zinc  deficiency  in 
malnourished  population  subsisting  on  rice  based  diets,  which  could  be 
qualitatively poor in meeting the zinc requirements. Bioavailability of zinc in any 
of the cereal based diets is poor due to the presence of phytate and fiber. Hence 
zinc intake and absorption is low in the diets of poor socio-economic population.41
SERUM  ZINC IN PREECLAMPSIA
            Several workers in the field of preeclampsia have suggested an association 
between zinc and preeclampsia which they have confirmed by the reduced serum 
zinc concentrations in women with preeclampsia.42, 43, 44, 45
A secondary zinc deficiency and low maternal plasma zinc concentrations 
can arise through a variety of mechanisms including poor availability of dietary 
zinc, genetic defects in zinc metabolism, physiological stress, disease or drug or 
toxicant  induced  changes  in  zinc  metabolism.  Thus  hypozincemia  can  be  a 
complication of numerous disease states that includes hypertension.46 
In preeclampsia there is an excessive acute phase response with increased 
levels  of  TNF-α and  IL-6.  One  effect  of  the  TNF-α and  IL-6  is  a  marked 
stimulation  of  the  synthesis  of  the  acute  phase  protein,  metallothionein. 
Metallothionein  is  a  low-molecular  weight  cystine-rich  protein  that  can  avidly 
bind  zinc  and  other  divalent  metals.  The  functions  of  this  protein  include 
protection against metal toxicity and short-term storage of zinc and copper and the 
scavenging of hydroxyl radicals.47 One consequence of cytokine induced increases 
in liver metallothionein, is hypozincemia.46 
Gordon et al48  showed that zinc deficiency is associated with a defect in 
platelet  aggregation  which  appears  to  be  related  to  altered  metabolism  of 
arachidonate and possibly to changes in the synthesis of prostaglandins. 
Cherry FF et al49 conducted a study with 272 adolescent pregnant women to 
ascertain the relationship of pregnancy outcome to plasma zinc levels. They found 
that women experiencing hypertension/toxemia were found to have significantly 
lower plasma zinc levels. Kumru S et al50 have said that the serum zinc levels were 
43% lower in the preeclamptic group compared with the normal pregnant women.
COPPER
Copper is an essential trace element important for growth and development. 
Copper dependent functions in our body include formation of melanin and keratin, 
synthesis  of  connective  tissue  and  myoglobin,  hemoglobin  synthesis,  energy 
production,  synthesis  of  neurotransmitters  (catecholamines),  free  radical 
scavenging (superoxide  dismutase),  immune function,  formation  of  the  myelin 
sheath of  nerves, fertility and maintenance of pregnancy.
Copper is absorbed maximally in the duodenum with 50-80% of ingested 
copper  being  absorbed.  Absorbed  copper  is  bound  primarily  by  albumin  and 
transported  to  the  liver.  In  the  liver  95%  of  the  copper  is  incorporated  into 
ceruloplasmin (Ferroxidase I). In addition, a portion of copper is also incorporated 
in bile. A third portion of copper is incorporated into intracellular enzymes, such 
as superoxide dismutase and cytochrome oxidase. Copper is excreted primarily in 
faeces and its losses in urine and sweat amount to less than 3% of the dietary 
intake.
In the liver, copper is stored mostly as metallothionein like cuproproteins. 
Metallothionein is a copper and zinc binding protein present in most, if not all, 
tissues  of  higher  eukaryotes.  The  regulation  of  copper  metabolism  is  quite 
complex. The liver is the key organ, with copper being stored there and released as 
ceruloplasmin to maintain the blood levels.
Normal serum copper level = 0.8 – 1.55 mg/L
Ceruloplasmin
Ceruloplasmin is an α2 - globulin containing copper, generated in liver. Its 
content in the blood of normal individuals is maintained at 300-400mg / litre of 
blood plasma. It is an enzyme protein containing 6 copper atoms.
It is the major extracellular antioxidant. Its antioxidant property is through 
its oxidase activity.51  Ceruloplasmin is one of the varied agents that produces non 
enzymatic detoxification of reactive oxygen species like H2O2.52 The antioxidant is 
characterized as an " acute phase reactant” and is one of the essential factors of 
natural organism defense.  So ceruloplasmin levels are high in various neoplastic 
and inflammatory states.
Since ceruloplasmin contains a major portion of plasma copper, changes in 
its  concentration  determine  the  copper  concentration  in  serum  with  very  few 
exceptions.53
SERUM COPPER IN PREGNANCY
 Increased  concentration  of  serum  copper  and  ceruloplasmin  occur  in 
pregnancy  and  with  estrogen  therapy.  The  serum  copper  concentration  was 
approximately  twice  that  of  normal  non  pregnant  value  and  these  high  levels 
persisted throughout the gestation and into early postpartum. Elevation in serum 
copper  levels  has  been  ascribed  to  increased  estrogen  levels  and  progesterone 
concentration.54
It  has  been  earlier  reported  that  the  increase  in  serum  copper  during 
pregnancy  is  mainly  in  bound  form  due  to  increase  in  the  carrier  protein, 
ceruloplasmin,  in  response  to  stimulation  by  elevated  levels  of  maternal 
estrogens.55 Estrogens  increase  serum  copper  levels  probably  by  increasing 
hepatic ceruloplasmin synthesis. 
Pathak Priyali and Kapil Umesh38 have said that pregnancy is associated 
with increased copper  retention,  which may be partly  due to  decreased biliary 
copper excretion induced by hormonal changes, typical during pregnancy. 
           Increased copper levels may also be due to the mobilization of copper from 
maternal tissues56, especially from the liver. This in turn has been associated with 
an increase in blood estrogens.57
         Okonofua FE et al45  have found that in Nigerian woman there is a 100% 
increase in copper levels in pregnant women over non - pregnant levels at the end 
of pregnancy. Martin Lagos F et al58 have proclaimed that serum copper levels in 
the second and third trimesters of pregnancy were significantly higher (P<0.05) 
than those determined during the first  trimester and for  non pregnant  controls. 
Anand S et  al59 have  said  that  serum copper  levels  rose  with  the  progress  of 
pregnancy and the increase was statistically significant (P<0.005) in the second 
trimester. 
SERUM COPPER IN PREECLAMPSIA
Acute  phase  responses  found  in  preeclampsia  are  complicated  by 
perturbations  in  copper  metabolism  resulting  in  hypercupremia.  The 
hypercupremia is a hallmark of the acute phase response.47 The increase in serum 
copper levels may be related to increased levels of ceruloplasmin, a positive acute 
phase reactant.17,23
Many  evidences  point  to  the  increased  levels  of  serum  copper  and 
ceruloplasmin in preeclamptic women as compared with that of normal pregnant 
women.54, 60, 61, 62   Zehra Serdar et al63  have reported in their study that copper and 
ceruloplasmin levels in serum were significantly increased in women with severe 
preeclampsia.  Aksov  et  al64 have  stated  that  serum ceruloplasmin  levels  were 
increased along with an increase in malondialdehyde levels in the preeclamptic 
group compared with the normotensive pregnant group. 
                                             
           
CALCIUM
Calcium is the most prevalent cation found in our body and its deficiency is 
related  to  hypertensive  disorders  of  pregnancy  and  related  maternal  and  fetal 
adverse outcomes. 
Calcium  exists  in  three  physico-chemical  states:  free  ionized  calcium 
(50%),  protein bound calcium (40%) and calcium combined with small  anions 
(10%).Of the protein bound calcium  fraction, 80% is associated with albumin and 
20% with globulin.65 Physiologically calcium is classified as intracellular or extra 
cellular calcium. 
The daily intake of calcium averages 25 mmol (1g). Of this only 6 mmol is 
absorbed by active transport in the proximal small bowel. Normally 98% of the 
calcium filtered by the kidneys is reabsorbed in the proximal tubule.
Total serum calcium - 8.6 - 10.3 mg/dl 
CHANGES IN CALCIUM HOMEOSTASIS DURING PREGNANCY
 Calcium  homeostasis  is  an  important  aspect  of  maternal  and  fetal 
physiology during gestation and recent evidence implicates alterations in calcium 
metabolism, in the pathogenesis of hypertension during pregnancy. Deficiencies in 
calcium intake have been linked to preeclampsia / eclampsia, and hypocalciuria 
and deviations in both 1,25 dihydroxy vit D3 and parathyroid hormone have been 
shown in women with preeclampsia.66
The physiologic demand for calcium is elevated by as much as 200 - 300mg 
/ day during pregnancy and lactation. According to Lorrene D Ritchie et al67 fetal 
calcium demand is met by increased maternal intestinal absorption, early breast - 
milk calcium was provided by maternal renal calcium conservation and loss of 
spinal trabecular bone, a loss that was recovered post menses. 
In  pregnancy  there  is  approximately  twofold  increase  in  the  circulating 
levels of 1,25 Dihydroxy vitamin D68, produced in maternal kidneys along with 
contributions from maternal  decidua,  placenta and fetal kidneys. 1,25 Dihydroxy 
vitamin  D  promotes  the  absorption  of  calcium  from  small  intestine  and  also 
enhances the reabsorption of calcium from the proximal convoluted tubules of the 
kidneys. Other hormones contributing to the regulation of calcium metabolism are 
prolactin, placental lactogen and PTH- related protein. Hence in pregnancy, there 
is an increase in calcium absorption.
Though there is an increase in calcium absorption during pregnancy, the 
total calcium levels fall in pregnancy.69 This reduction in total calcium may be due 
to the normal expansion of maternal  blood volume and the pregnancy induced 
increase in urinary calcium excretion.70 Pitkin RM et al71 have stated that the major 
portion of decline in maternal serum calcium reflects changes in the non ionized 
(albumin  -  bound)  fraction  while  the  ionic  portion  declines  only  slightly. 
According  to  Reddy  G  S  et  al72 increased  calcium  transfer  from  maternal 
circulation to the developing fetus may result in lowered serum calcium levels in 
pregnancy.
SERUM  CALCIUM IN PREECLAMPSIA
Considerable interest has developed regarding the role of calcium in the 
regulation  of  blood  pressure.  The  effect  of  calcium  on  blood  pressure  may 
influence the incidence and /or gestational age of development of preeclampsia.
The  precise  factors  involved  in  the  pathogenesis  of  pregnancy  induced 
hypertension /preeclampsia is unclear, but several associated alterations in calcium 
metabolism have been identified. They include decrease in serum 1,25 dihydroxy 
vitamin D concentration, decrease in serum ionized calcium concentration73 and a 
decrease in urinary calcium excretion. Whether these biochemical abnormalities 
are  a  consequence  of  PIH/preeclampsia  or  result  from  impaired  calcium 
absorption, inadequate dietary calcium intake, or both is unclear.
There are several studies showing a significant relationship between low 
serum calcium levels and preeclampsia.50,61,62,74,75  According to Kumru S et al50, the 
serum calcium is  10% lower  in  the  preeclamptic  women compared  to  that  of 
normal pregnant women. Borella P et al61 has stated that in EPH gestosis (edema, 
proteinuria,  hypertension),  total  calcium  was  reduced  with  a  reduction  in  the 
plasma calcium / magnesium ratio.
There are some studies showing an inverse relationship between calcium 
intake and the incidence of hypertensive disorders of pregnancy.70,76 This fact has 
also been supported by many calcium supplementation studies like the one done 
by Jose Villar et al.77 
Role of calcium in blood pressure regulation
Women  with  preeclampsia  have  elevated  intracellular  calcium 
concentrations in erythrocytes, platelets and vascular smooth muscle cells.78 In the 
prospective  study by  Zemel  et  al79,  although no  significant  difference  in  basal 
platelet intracellular calcium concentration was found, preeclamptic patients had 
significantly greater intracellular calcium concentrations in platelets in response to 
stimulation by arginine vasopressin than did normotensive women. If established, 
however,  an  increase  in  intracellular  calcium in  vascular  smooth  muscle  cells 
during pregnancy is consistent with development of vasoconstriction and resultant 
hypertension.
Alternatively it has been hypothesized that calcium affects smooth muscle 
cell  contractility  indirectly  by  influencing  the  production  of  other  vasoactive 
agents  such  as  nitric  oxide,  prostacyclins,  or  angiotensin  (via  the  renin-
angiotensin- aldosterone metabolic pathway).78 Calcium supplementation appears 
to affect circulating concentrations of parathyroid hormone and renin, which may 
modulate intracellular ionized calcium, resulting in the observed effect on smooth 
muscle relaxation.80
The  biochemical  mechanism  responsible  for  the  possible  increase  in 
intracellular  calcium  and  concomitant  decrease  in  extracellular  calcium  is 
presently unclear.
AIM OF THE STUDY
Deficient  or  excessive  levels  of  minerals  have  for  a  long  time  been 
associated  with  various  pregnancy  outcomes,  preeclampsia  being  one  among 
them. The information available on the involvement of minerals like zinc, copper 
and  calcium  in  preeclampsia  has  been  reviewed  and  the  present  study  was 
undertaken with the following objectives.
• To  determine  the  serum  zinc  and  copper  levels  in  non  pregnant,  normal 
pregnant and preeclamptic women and to analyse whether their levels in the 
three groups differed statistically.
• To determine the serum calcium levels in non pregnant, normal pregnant and 
preeclamptic women and to analyse whether their levels in the three groups 
differed statistically.
• To determine the serum albumin levels in the three groups, analyse its variation 
in the groups and to correlate its level with that of the minerals.
MATERIALS AND METHODS
The present cross sectional study was carried out on one hundred and fifty 
female subjects  in the age group of 20-32 years.  Out of the hundred and fifty 
women, fifty were non pregnant, fifty were normal pregnant and the other fifty 
were preeclamptic women. The preeclamptic and normal pregnant women were 
from  the  wards  and  out  patient  Departments  of  Kasturba  Gandhi  Hospital, 
Triplicane and Institute of Obstetrics and Gynaecology, Egmore. Friends, relatives 
and their family members who formed the non pregnant group, constituted the 
control group for the study.
The subjects selected for this study were not supplemented for zinc and 
copper.  Low dose calcium was supplemented to the pregnant and preeclamptic 
groups, but with poor compliance.
NON PREGNANT GROUP (50 members)
This group consisted of non pregnant women in the age group of 20-32 
years without any preexisting medical illnesses like diabetes, hypertension, renal 
and cardiovascular disease
NORMAL PREGNANT GROUP (50 members)
This group consisted of
1. Normotensive  primigravidae  in  the  age  group  of  20-32  years  and 
gestational age ≥ 28 weeks of pregnancy (3rd trimester).
2. No complications of pregnancy.
PREECLAMPTIC GROUP (50 members)
Inclusion criteria
Primigravidae in the age group of 20-32 years  and gestational age  ≥ 28 
weeks of pregnancy (3rd trimester) presenting with 
1. Persistent elevation of blood pressure  ≥140/90 mmHg confirmed by two 
measurements (in the sitting posture at least six hours apart) or an increase 
of at least 30mmHg of systolic or 15mmHg diastolic over baseline value.
2. Proteinuria ≥ 0.3g / 24 hours urine specimen (or) ≥ 1+ dispstick.
Exclusion criteria
Women  with history of preexisting hypertension, diabetes, renal or heart 
disease.
SAMPLE COLLECTION
             The syringes, centrifuge tubes and eppendorfs were all washed well with 
detergent solution and rinsed thoroughly with tap water. They were then soaked in 
5% HNO3 solution overnight and afterward rinsed individually for six times, with 
deionised water.  After this they were all dried in a hot air oven. These treated 
syringes, centrifuge tubes and eppendorfs only were used for sample collection, 
transport  and  storage.  This  was  done  to  avoid  any pre  analytical  error  due  to 
contamination.
8cc of venous blood (from antecubital vein) was collected from each of the 
one hundred and fifty subjects selected for the study. The blood was immediately 
transferred  to  two  tubes.  First  one  was  the  pretreated  centrifuge  tube  and  the 
second  one  was  a  glass  tube  containing  the  anticoagulant  mixture  (Potassium 
oxalate and sodium fluoride in the ratio of 3:1). The blood in the second tube was 
analysed for glucose to confirm the exclusion of diabetic subjects. 
           The blood in  the pretreated centrifuge tubes were allowed to clot and the 
serum  separated.  The  serum  from  each  sample  was  again  transferred  to  two 
eppendorfs. The serum in one eppendorf was for estimation of zinc and copper; 
the serum in the other eppendorf was for estimation of calcium and albumin. The 
serum samples in the eppendorfs were stored at -20oC until the analysis.
ESTIMATION OF ZINC AND COPPER
The estimation  of  zinc  and copper  was  done  in  the  Atomic  Absorption 
Spectrophotometer - PERKIN ELMER - 3110.
PRINCIPLE
Atomic absorption
The ground state atom absorbs light energy of a specific wavelength as it 
enters the excited state. As the number of atoms in the light path increases, the 
amount  of  light  absorbed  also  increases.  By  measuring  the  amount  of  light 
absorbed, a quantitative determination of the amount of analyte can be made.
Here in atomic absorption, the only function of the flame is to convert the 
sample aerosol into atomic vapour. Here the element is not appreciably excited but 
is merely dissociated from its chemical bonds and placed in an unexcited ground 
state (Neutral atom), which is capable of absorbing light from the primary light 
source.  The  neutral  atom  is  at  a  low  energy  level  in  which  it  is  capable  of 
absorbing radiation at  a  very  narrow bandwidth  corresponding to  its  own line 
spectrum.
ATOMIC ABSORPTION INSTRUMENTATION
There are 5 basic components of an atomic absorption instrument.
1. The light source that emits the spectrum of the element of interest.
2. An "absorption cell" in which atoms of the sample are produced. (Flame, 
graphite furnace, MHS Cell, FIAS cell, FIMS cell).
3. A monochromator for light dispersion.
4. A detector, which measures the light intensity and amplifies the signal.
5. A  display  that  shows  the  reading  after  it  has  been  processed  by  the 
instrument electronics.
INSTRUMENT CALIBRATION
Quantitative  measurements  in  atomic  absorption  spectrophotometer  are 
based  on  Beer's  Law,  which  states  that  concentration  is  proportional  to 
absorbance. If the analytic concentration of all the samples to be analysed falls 
with in the linear range, one calibration standard should be used.
ESTIMATION OF ZINC
Stock standard solution - 1000 mg/L  in 1% HCl
Working standard - 0.8 µg/ml is prepared in 5% glycerol
Wavelength 
used
(nm)
Slit width
(nm)
Standard 
concentration
(mg/L)
Linearity 
range
(mg/L)
Sensitivity
(mg/L)
213.9 0.7 0.8 1 0.018
Recommended flame - Air acetylene
Zinc bulb - 0303 – 6081
Method
First  the  atomic  absorption  spectrophotometer  was  calibrated  with  the 
standard.  Then  the  samples  were  fed  into  the  machine  and  the  displayed 
concentrations were read and documented. For every 10 samples fed, the machine 
was calibrated once with the standard.
Reference range:  70 – 120 µg/dl    (or)     0.7-1.2 mg /L
ESTIMATION OF COPPER
Stock standard solution - 1000 mg/L   in  1% HNO3
Working standard - 4 mg/L  of working standard is 
prepared in 10% glycerol
Wavelength 
used
(nm)
Slit width
(nm)
Standard 
concentration
(mg/L)
Linearity 
range
(mg/L)
Sensitivity
(mg/L)
324.8 0.7 4 5 0.077
Recommended flame - Air acetylene
Copper bulb - 0303 - 6024
Method
First  the  atomic  absorption  spectrophotometer  was  calibrated  with  the 
standard.  Then  the  samples  were  fed  into  the  machine  and  the  displayed 
concentrations were read and documented. For every 10 samples fed, the machine 
was calibrated once with the standard.
Reference range:  80 – 155 µg/dl    (or)     0.8-1.55 mg /L
ESTIMATION OF CALCIUM (OCPC method)
Serum total calcium has been measured photometrically using the semi auto 
analyser by O - cresolphthalein complexone method.
Principle
Calcium  in  an  alkaline  medium  combines  with  O-cresolphthalein 
complexone to form a purple coloured complex [O-cresolphthalein complexone 
(CA++)2 ]. The intensity of the coloured complex produced is directly proportional 
to the concentration of calcium present in the sample.
Calcium + O-cresolphthalein complexone   →  Purple coloured complex
Sample   Fresh clear unhemolysed serum.
Reagents
L1 : Buffer reagent                                  (75 ml)
L2 : Colour reagent                                 ( 75ml)
S : Calcium standard (10mg/dl)            (5 ml )
Reagent preparation  Reagents are ready to use.
Procedure
Wavelength / Filter : 570nm / yellow
Temperature : Room temp
Light path : 1 cm
Pipette into clean dry test tubes labeled as Blank (B), Standard (S), and Test 
(T).
Addition sequence B (ml) S (ml) T (ml)
Buffer Reagent (L1) 0.5 0.5 0.5
Colour Reagent (L2) 0.5 0.5 0.5
Distilled water 0.02 - -
Calcium standard (S) - 0.02 -
Sample - - 0.02
Mix well and incubate at room temperature (25oC) for 5 minutes. Measure 
the absorbance of the standard (Abs.S) and Test sample (Abs.T) against the Blank, 
within 60 minutes.
Calculations
Calcium in mg/dl    =
Abs.T
Abs.S
x    10
Linearity This procedure is linear up to 18 mg/dl
Reference range
Serum / plasma: 8.7 - 11.0 mg/dl.
System Parameters
Reaction End point
Wavelength 570nm
Zero setting Reagent blank
Incubation temperature room temp.
Incubation time 5 minutes
Sample volume 0.02 ml
Reagent volume 1.00 ml
Standard 10mg/dl
Reaction slope Increasing
Linearity 18mg/dl
Units mg/dl
           
ESTIMATION OF ALBUMIN
Serum albumin has  been  measured  photometrically  using  the  semi  auto 
analyser by Bromocresol green dye binding method.
Principle
Determination  of  albumin  in  serum or  plasma  is  based  on  the  specific 
binding of the dye bromocresol green to albumin in the presence of other plasma 
or serum proteins. The binding affinity between the dye and albumin is very high. 
At pH 3.68, albumin acts as a cation and binds to the anionic dye, forming a green 
complex, the absorbance of which is measured at 630 nm.
Reagents
Reagent 1(100 ml) - Albumin Reagent (100 ml) 
                                  (Bromocresol green, buffer pH 3.68)
Reagent 2(3 ml) - Albumin standard (4 gm/dl)
Working Reagent preparation
Reagent 1 (Albumin Reagent) and Reagent 2 (Albumin standard) are ready 
for use as  supplied.
Specimen 
Unhaemolysed serum or plasma serum is preferred.
System Parameters
Mode End point
Wavelength 630 nm (600 - 630nm)
Temperature Room temperature
Optical path length 1 cm
Zero setting Reagent blank
Incubation time (minutes) 1
Sample volume 10 µl
Reagent volume 1000 µl
Concentration of the Standard 4gm/dl
Linearity Up to 6 gm/dl
Maximum absorbance limit 2.00
Units gm/dl
Procedure
Pipette into clean dry test tubes and perform the tests as given below:
Pipette into tubes 
marked Blank (ml) Standard (ml) Test (ml)
Serum or plasma - - 0.01
Albumin standard - 0.01 -
Albumin Reagent 1.0 1.0 1.0
Mix well. Incubate at room temperature for 1 minute.
1. Blank the analyser with the reagent blank.
2. Aspirate standard followed by tests.
Calculation
Albumin (gm/dl)    = Abs.TAbs.S x    4
Reference range
Adults : 3.5 - 5.0 gm/dl
Children : 2.4 - 4.8 gm/dl
RESULTS
In the present study the serum levels of zinc, copper, calcium and albumin, 
in  non  pregnant,  normal  pregnant  and  preeclamptic  women  were  assessed, 
analysed  and  tabulated.
The results of the above said parameters obtained in the three groups are 
given in Tables 1-3. Table -1 signifying 50 non pregnant women, Table - 2 that of 
50  normal  pregnant  women and Table-3  that  of  50  preeclamptic  women.  The 
mean and standard deviation (S.D) for each parameter analysed in the different 
groups are also given in the respective tables. The same has also been illustrated as 
bar diagrams from figures 1 to 4.
         To determine how far the mean levels of the various biochemical parameters 
obtained in the normal pregnant group and the preeclamptic group varied from the 
corresponding means  of  the  control  group,  each  of  the  former  2  groups  were 
compared with that of the latter in Tables - 4 & 5 respectively. Similarly to obtain 
at the difference between the normal pregnant and preeclamptic groups, the mean 
and standard deviation of the parameters in the 2 groups were compared in Table - 
6. The statistical significance of the variation in levels were obtained from the p 
value which has been calculated using the students `t' test. The obtained p value 
and the corresponding statistical significance on comparison of the 3 groups with 
one another are also shown in the tables. The correlation between serum albumin 
and the minerals zinc, copper and calcium are given in Tables - 7 to 9 respectively.
TABLE -1  Serum zinc, copper, calcium and albumin levels in non pregnant women
S.No. Zinc (mg/L) Copper  (mg/L) Calcium (mg/dl) Albumin  (g/dl)
1 0.67 1.2 10.6 4.6
2 0.48 1.2 9.9 4
3 0.62 1.7 9.5 4
4 0.53 2 9.5 3.1
5 0.36 1.8 9.4 3.7
6 0.51 1.3 8.8 4.1
7 0.58 1.3 9.3 4.1
8 0.58 1.4 9.2 3.8
9 0.47 1.3 8.8 4
10 0.5 1.6 9.9 3.9
11 0.49 1.2 10.3 3.9
12 0.44 1.4 9.9 4
13 0.46 1.6 10 4
14 0.29 2 8.3 3.2
15 0.45 2.6 10.4 3.6
16 0.4 1.8 10.1 4.1
17 0.39 1.8 10.5 3.7
18 0.41 1.3 9.1 3.8
19 0.31 1 8.8 3.5
20 0.49 1.3 8 4.1
21 0.74 1.4 9.9 3.8
22 0.52 1.5 10.4 3.9
23 0.68 1.7 9.9 3.3
24 0.57 1.4 9.5 3.9
25 0.6 1.7 10.3 4
26 0.64 1.3 10.5 4
27 0.47 1.2 9.7 4.1
28 0.61 1.8 10.4 4
29 0.53 1.9 9.9 2.8
30 0.36 1.8 8.3 3.3
31 0.52 1.4 8.8 3.9
32 0.61 1.4 8.1 4
33 0.65 1.5 8.6 3.8
34 0.53 1.3 9.3 3.9
35 0.54 1.7 10.1 3.8
36 0.47 1.1 10.2 4.1
37 0.45 1.3 10.5 3.9
38 0.49 1.6 10.3 4.1
39 0.3 2.1 9.6 3.1
40 0.43 2.6 10.4 3.8
41 0.58 1.9 10 4.1
42 0.36 1.8 10.2 3.7
43 0.41 1.4 10 3.9
44 0.27 1.1 9 3.5
45 0.43 1.4 9 4.3
46 0.48 1.3 8.2 4
47 0.46 1.4 9.5 4.2
48 0.64 1.6 9 3.3
49 0.5 1.4 9.4 4.6
50 0.6 1.6 8.7 4
Mean 0.50 1.55 9.56 3.85
S.D. 0.11 0.34 0.73 0.35
TABLE -2 Serum zinc, copper, calcium and albumin levels in normal pregnant women
S.No. Zinc (mg/L) Copper  (mg/L) Calcium (mg/dl) Albumin  (g/dl)
1 0.57 2.5 7.4 3.1
2 0.46 2.6 7.3 3.2
3 0.41 2.7 8.6 3.2
4 0.47 1.8 7.1 3.1
5 0.43 2.4 7.6 3.1
6 0.43 2.2 8.5 3.4
7 0.26 2.9 9.3 3.1
8 0.28 1.8 7.8 3.3
9 0.33 2.3 8.3 3.1
10 0.55 1.9 8.1 3.2
11 0.44 2.7 10.4 2.9
12 0.39 2.1 8.6 3.2
13 0.53 1.9 8.3 3.1
14 0.41 2.8 10.3 3.1
15 0.37 1.8 10.5 3
16 0.54 2.9 10.3 3
17 0.55 2.5 8.3 3.1
18 0.53 2.4 9.6 2.9
19 0.51 3.5 9 3.2
20 0.53 2.4 7.8 3.1
21 0.53 2.2 7.6 3
22 0.46 2.1 7.7 3.2
23 0.59 2.6 8.2 3
24 0.37 2.4 8.7 3.4
25 0.35 3.3 9.1 3.2
26 0.49 2.4 8.1 3.6
27 0.35 2.4 9.4 3
28 0.31 2.6 8.6 3.3
29 0.48 2.6 8.7 2.6
30 0.41 1.9 7.6 3.4
31 0.47 2.5 8.1 3.3
32 0.4 2.7 8.4 3.3
33 0.54 1.8 9 3.4
34 0.5 2.2 8.7 3.5
35 0.43 1.9 8 3.2
36 0.37 2.4 8.5 3.3
37 0.45 1.9 10.4 3.1
38 0.55 1.8 8 3.4
39 0.61 1.7 9.4 3.3
40 0.34 2.7 9.7 3.1
41 0.39 2.8 9.8 3.3
42 0.36 2.7 8.8 3.2
43 0.34 2.1 7.8 3.5
44 0.37 2.4 9.4 3.4
45 0.42 2.5 10 3.6
46 0.38 2.2 9.8 3.3
47 0.32 2.3 10 3.6
48 0.4 1.7 7.9 3
49 0.4 2.5 7.8 3.2
50 0.41 2.4 9.1 3.1
Mean 0.44 2.36 8.71 3.20
S.D 0.08 0.40 0.92 0.19
TABLE -3  Serum zinc, copper, calcium and albumin levels in preeclamptic women
S.No. Zinc (mg/L) Copper  (mg/L) Calcium (mg/dl) Albumin  (g/dl)
1 0.43 3.3 10 3.2
2 0.44 3.2 8.6 2.8
3 0.4 3.2 8.5 3.4
4 0.41 2.7 8.7 3
5 0.55 3.4 8.9 3.3
6 0.44 2.4 8.6 3.2
7 0.32 3 10.1 3.1
8 0.36 3 8.8 3
9 0.39 3.8 9.1 3.2
10 0.45 2.7 8.7 3.5
11 0.48 3.3 8.2 3.3
12 0.33 2.5 8.1 3.2
13 0.33 2.4 8.2 3
14 0.3 2.1 8.1 2.8
15 0.39 3.3 10.1 2.9
16 0.37 2.6 7.9 2.9
17 0.33 2.8 8.6 3
18 0.23 2.9 10 3.1
19 0.32 2.4 8.8 2.9
20 0.33 2.7 8.9 3.1
21 0.31 2 8.7 3.2
22 0.6 2.6 8.9 3.1
23 0.45 2.3 7.8 3.1
24 0.47 2.5 8.2 3.2
25 0.41 2.8 7.9 3.3
26 0.45 3.1 9.8 3.1
27 0.59 2.8 7.9 3
28 0.41 2.8 7.4 2.9
29 0.33 1.7 7.6 3.2
30 0.48 2.1 7.9 3.3
31 0.39 3 8.4 3
32 0.3 2.5 9.7 3.1
33 0.33 3.3 8.8 3.3
34 0.32 3.1 8.5 3.2
35 0.38 2.1 9.3 3.3
36 0.44 3 9.6 3.2
37 0.29 2.6 8.8 3.3
38 0.33 1.8 9.7 3.2
39 0.38 2 7.9 3.1
40 0.42 2.7 8.4 3.4
41 0.46 1.9 7.8 3.3
42 0.5 3.3 9.1 3.2
43 0.28 1.9 8.2 3.1
44 0.39 2.8 9 3.2
45 0.33 2.9 8.3 3.4
46 0.31 2.8 7.9 3.2
47 0.35 2.5 8.5 3.1
48 0.36 2.8 8.4 3
49 0.45 3.7 8.2 3.1
50 0.41 3.4 8.4 2.9
Mean 0.39 2.73 8.64 3.14
S.D 0.08 0.5 0.7 0.16
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TABLE – 4                                                                     
Comparison of serum zinc, copper, calcium and albumin levels between 
non-pregnant and normal pregnant women
Groups Zinc (mg/L)
Copper
(mg/L)
Calcium
(mg/dl)
Albumin
(g/dl)
Non-Pregnant 0.5 ± 0.11 1.55 ± 0.34 9.56 ± 0.73 3.85 ± 0.35
Normal Pregnant 0.44± 0.08 2.36 ± 0.40 8.71 ± 0.92 3.20 ± 0.19
P value P<0.01 P<0.001 P<0.001 P<0.001
Significance MS↓ HS↑ HS↓ HS↓
MS-Moderately significant                  HS-Highly significant
TABLE - 5
Comparison of serum zinc, copper, calcium and albumin levels between 
non-pregnant and preeclamptic women
Groups Zinc (mg/L)
Copper
(mg/L)
Calcium
(mg/dl)
Albumin
(g/dl)
Non-Pregnant 0.5 ± 0.11 1.55 ± 0.34 9.56 ± 0.73 3.85 ± 0.35
Pre-eclamptic 0.39 ± 0.08 2.73 ± 0.5 8.64 ± 0.7 3.14 ± 0.16
P value P<0.001 P<0.001 P<0.001 P<0.001
Significance HS↓ HS↑ HS↓ HS↓
HS-Highly significant
TABLE - 6
Comparison of serum zinc, copper, calcium and albumin levels between 
normal pregnant and preeclamptic women
Groups Zinc (mg/L)
Copper
(mg/L)
Calcium
(mg/dl)
Albumin
(g/dl)
Normal  Pregnant 0.44 ± 0.08 2.36 ± 0.4 8.71 ± 0.92 3.20 ± 0.19
Pre-eclamptic 0.39 ± 0.08 2.73 ± 0.5 8.64 ± 0.7 3.14 ± 0.16
P value P<0.05 (P=0.012) P<0.001 P=0.68
P<0.05 
(P=0.047)
Significance S↓ HS↑ NS S↓
S -Significant               HS -Highly significant             NS -Non significant
TABLE - 7  
Correlation between serum zinc and albumin levels
Zinc Albumin
Pearson Correlation 1.000 .393
Sig. (2- tailed) 0.01
N 150 150
Positive significant  correlation  (P<0.01) exists  between serum zinc and 
albumin levels (r = .393).
TABLE - 8  
Correlation between serum copper and albumin levels
Copper Albumin
Pearson Correlation 1.000 -.674
Sig. (2- tailed) 0.01
N 150 150
Negative significant correlation  (P<0.01) exists between serum copper and 
albumin levels (r = -.674).
TABLE – 9
  Correlation between serum calcium and albumin levels
Calcium Albumin
Pearson Correlation 1.000 .396
Sig. (2- tailed) 0.01
N 150 150
Positive significant correlation  (P<0.01) exists between serum calcium and 
albumin levels (r = .396).
DISCUSSION
In the present study, serum zinc, copper, calcium and albumin levels have 
been  analysed  among  three  groups  (nonpregnant,  pregnant  and  preeclamptic 
women).
 To start with, the reference range obtained in the study from apparently 
normal nonpregnant females is scrutinized.
The mean serum zinc level of 0.50± 0.11 mg/L though higher to 0.36  ± 
0.06 mg/L obtained by Ajose A et al81,  is well within the reference range obtained 
by  Pathak  Priyali  et  al82   who  have  conducted  their  study  in  New  Delhi  in 
populations with high calorie intake and low calorie intake. In the high calorie 
intake group the zinc level was 0.63 ± 0.15 mg/L while in the low calorie intake 
group  it was 0.59 ± 0.13 mg/L. However the reference range for zinc in this study 
and that of Pathak Priyali et al are much lower to 0.947 ± 0.265 mg/L of Martin 
Lagos et al58  and that of 0.7 to 1.2 mg/L quoted by David B.Milne83 in Tietz text 
book of Clinical Chemistry.
It  should be  taken into account  that  the latter  3 persons  have given the 
reference range for serum zinc by studying the Western population, compared to 
the work of Pathak Priyali et al and the present study which were undertaken with 
Indians, who consume cereals as their staple diet. According to Bhaskaram P41, in 
Indians, there is occurrence of milder grades of zinc deficiency in malnourished 
population subsisting on rice based diets. This could be due to the presence of 
factors  like phytate and fiber in cereals,  which form insoluble complexes with 
zinc, leading to its reduced absorption. Hence the reference range of zinc is lower 
in this study, compared to that of western population.
On the other hand, the serum copper mean of 1.55 ± 0.34 mg/L obtained for 
the controls of this study is at the upper limit of the reference range of 0.8 to 1.55 
mg/L given in Tietz text book of Clinical Chemistry.83 It is also higher to the level 
of 1.092  ± 0.362 mg/L of Martin Lagos et al.58 This difference in the level of 
copper in the control group when compared to the values given in Tietz textbook 
of  clinical  chemistry and that  given by  Martin  Lagos et  al  can be  once again 
explained in terms of racial variation of the population studied.
The mean calcium level  of 9.56  ± 0.73 mg/dl falls  within the reference 
range of 8.7 to 11mg/dl of the kit method selected for the study and that of 9.5 ± 
1.6 mg/dl obtained by Malas NO et al.75 It also falls within the reference range of 
8.6 - 10 mg / dl given in Tietz text book of Clinical Chemistry.65
Among the 4 parameters,  it  is  found that calcium and albumin levels in 
controls fall well within the reference range quoted by previous workers in the 
field and that in standard textbooks. The lower mean levels of zinc and the higher 
mean levels  of  copper  in  controls  of  this  study  compared  to  several  previous 
studies  have  been  attributed  to  the  racial  variation.  Therefore  the  mean levels 
obtained for all the 4 parameters from apparently normal nonpregnant women can 
be accepted as the valid reference range for this study.
Comparison of the serum zinc levels obtained in the normal pregnant and 
preeclamptic women, with the above reference range of the minerals reveal the 
following.  From  table-  4  it  is  evident  that  serum  zinc  levels  are  lowered  to 
significant  levels  (P<0.01)  in  the  normal  pregnant  women,  from its  reference 
range.  This  reduction of  serum zinc  levels  in  pregnant  women from their  non 
pregnant counterparts correlates well with the previous studies of Giroux et al33, 
Sheena Tuttle  et al34,  Christine et  al35, ,  Janette  Taper et al36,  Isabelle  et  al37 , 
Pathak Priyali et al38 and Tamura et al.39
Various reasons can be attributed to this decrease in serum zinc level in 
pregnancy. In pregnancy 75% of the decrease in total serum zinc can be due to the 
decrease  in  albumin  bound  zinc  leading  to  hypozincemia  secondary  to 
hypoalbuminemia as suggested by Giroux et al.33   It may also be due to plasma 
volume expansion resulting in hypozincemia and hypoalbuminemia as indicated 
by Sheena Tuttle et al34 or it may be due to a normal physiological adjustment to 
pregnancy in response to hormonal changes, hemodilution or a combination of the 
above, as pointed out by Tamura et al.39
The  serum  zinc  levels  in  preeclamptic  women  are  lowered  to  highly 
significant levels (P<0.001) compared to the reference range which is evident in 
Table-5.  Preeclampsia  is  characterized  by  excessive  acute  phase  response 
(inflammatory response) as indicated by Redman et al.15 In acute phase response 
cytokines like IL-1, IL-6 and TNF-α are released which in turn induces the hepatic 
synthesis of various acute phase proteins,  one of them being  metallothionein.22 
Metallothionein causes increased sequestration of zinc in maternal liver, resulting 
in  hypozincemia, as indicated by Carl L. Keen et al.46 This decrease in serum zinc 
may also be  associated  with a  defect in platelet aggregation which appears to be 
related to alteration in the metabolism of arachidonate and to possible changes in 
the synthesis of prostaglandins, as suggested by Gordon et al.48
Hence it is clear that significant lowering of zinc from its reference range 
occurs in both the normal pregnant and the preeclamptic women. But when Table - 
6 is scrutinized, it is obvious that in preeclamptic women, serum zinc levels are 
even  lower  to  that  in  normal  pregnant  women.  This  difference  which  is 
statistically significant (P<0.05) correlates to the observations of James Roberts et 
al1, Bassiouni et al44, Carl L Keen et al46,  Gordon et al47, Cherry et al49 who have 
obtained  significantly  lower  levels  of  serum  zinc  in  preeclamptic  women 
compared to their  normal  counterparts.  Thus the greater  degree of  decrease  in 
serum zinc levels of preeclamptic women can probably be due to the excessive 
acute phase response in preeclampsia, compared to the proinflammatory stimulus 
associated with normal pregnancy.15
On analysis of serum copper in normal pregnant women, it is clear that the 
level is increased to a highly significant degree (P<0.001) from the reference range 
(Table-4). This correlates well with the studies by Pathak Priyali et al38, Okunofua 
PE et al45, Sheila et al54, Martin Lagos et al58 and  Anand S et al.59
The increase in serum copper in normal pregnancy can be attributed to the 
increase in bound form of the mineral as a result of the increase in the carrier 
protein ceruloplasmin, in response to stimulation by elevated maternal estrogens, 
as  indicated  by  Pathak  Priyali38 et   al.  It  can  also  be  due  to  increase  in  both 
estrogen and progesterone levels, as pointed out by Sheila et al.54
Increase in the level of serum copper to highly significant levels (P<0.001) 
from the reference range is also evident in preeclamptic women (Table-5). This 
increase  can  be  related  to  the  excessive  acute  phase  response  in  preeclampsia 
which is characterized by increases in plasma ceruloplasmin, complement activity, 
α1-antitrypsin, haptoglobin and reduced albumin and transferrin,  as suggested by 
Vince GS et al.29  Ceruloplasmin,  a copper binding carrier protein,  is  the major 
circulating form of copper. It is also a positive acute phase reactant. The increased 
level  of  serum ceruloplasmin  may  be  related  to  the  increased  levels  of  serum 
copper as stated by Carl L.keen et al46 or Zehra Serdar et al.63
On scrutinizing Table-6 regarding the elevation of serum copper levels in 
both  preeclamptic  women  and  normal  pregnant  women,  it  is  clear  that  the 
elevation of the mineral in preeclamptic women is higher to that of the pregnant 
women resulting  in  a  highly  significant  difference  (P<0.001)  between the  two 
elevated levels. This finding correlates with the studies by Vince GS et al29 , Sheila 
et al54, Fattah MM et al60, Borella P et al61, Zhao  F et al62,  Zehra Serdar et al63 and 
Aksov  et  al64  who  have  shown  a  greater  increase  in  serum copper  levels  in 
preeclamptic  women  compared  to  the  normal  pregnant  women.  The  higher 
elevation of serum copper in preeclamptic women can be viewed in similar terms 
to that of zinc and therefore attributed to the excessive acute phase response of 
preeclampsia.
The serum calcium levels in normal pregnant women are lowered to highly 
significant levels (P<0.001) from its reference range (table - 4). The reduction in 
serum calcium during pregnancy can be due to the normal expansion of maternal 
blood  volume  and  to  increase  in  excretion  of  urinary  calcium as  reported  by 
Lorrene D Ritchie et al.70 The decrease of total calcium can also be a reflection of 
the fall  in serum albumin and the albumin bound to total calcium as stated by 
Pittin RM and Gebhardt MP.71 It may also be due to the increased calcium transfer 
from maternal circulation to the developing fetus as suggested by Reddy GS.72
As per Table-5 the serum calcium levels in preeclamptic women are also 
lowered  to  highly  significant  levels  (P<0.001)  from its  reference  range.   The 
decrease in serum calcium as suggested by Lorrene D Ritchie et al70, may be due 
to reduced dietary intake of calcium because the subjects analysed belong to the 
lower  economic  strata.  It  can  also  be  the  result  of  the  excessive  acute  phase 
response seen in preeclampsia because it has already been reviewed that calcium is 
a negative acute phase reactant. As a result of this decrease in serum calcium i.e. 
extracellular  calcium,  intracellular  calcium  may  be  increased  as  suggested  by 
Lorrene  D Ritchie  et  al.67 This  intracellular  calcium in  preeclampsia  has  been 
found to be more pronounced in RBCs,  platelets  and vascular smooth cells  as 
stated by Jorge A. Prada et al.78 He has suggested that the increase in calcium in 
vascular  smooth  muscle  cells  will  have  a  direct  effect  by  causing   abnormal 
contraction  of  smooth  muscle  cells  and  an   indirect  effect  by  influencing  the 
production  of  other  vasoactive  agents  like  nitric  oxide,  prostacyclins  and 
angiotensin which will  increase the vascular resistance and the blood pressure, 
resulting in preeclampsia.  Hence the decrease of serum calcium and associated 
increase of intracellular calcium can also be the reason for preeclampsia in the 
subjects analysed.
In  Table-6  we  find  that  statistically  there  is  no  difference  between  the 
lowered  calcium levels  of  preeclamptic  women (p=0.68)  and  those  of  normal 
pregnancy. This finding of the study does not correlate with those of Kumru S et 
al50, Borella P et al61, Zhao F et al62 , Huang HM et al74 and Malas NO et al75 who 
have shown significantly lower serum calcium levels in preeclamptic women to 
that in normal pregnancy.
This is rather surprising because albumin and calcium, negative acute phase 
reactants  get  reduced  when  there  is  an  acute  phase  response.17,23  Therefore  in 
preeclampsia  where  there  is  albuminuria  along  with  exaggerated  acute  phase 
response it is natural to expect   a lower level of serum albumin and calcium in the 
condition in comparison to normal pregnancy where plasma volume expansion is 
the  only  contributory  factor.  As  per  expectation  the  serum  albumin  level  is 
significantly lower (P<0.05) in preeclampsia than to its level in normal pregnancy 
(Table-6).Since 40% of the calcium is normally bound to albumin and since it is 
by self a negative acute phase reactant,  theoretically there should be a greater 
decrease of serum calcium level in preeclampsia unlike that of our study where 
though the serum calcium is lower to its level in normal pregnancy, the lowering is 
not sufficient to produce any statistically significant difference.
As Lorrene D Ritchie et al67 has suggested that there is decreased urinary 
excretion  of  calcium  in  preeclampsia  unlike  that  of  albumin,  the  absence  of 
statistically  lower  level  of  calcium  in  preeclampsia  can  be  attributed  to  this 
decrease of its excretion.
The  serum  albumin  levels  in  normal  pregnancy  are  lowered  to  highly 
significant  levels  (P<0.001)  compared  to  its  reference  range  (Table-4).  This 
hypoalbuminemia of pregnancy could be the result of plasma volume expansion as 
suggested by Sheena Tuttle et al34 and Lorrene D Ritchie et al.67
The  serum  albumin  levels  in  preeclamptic  women  are  also  lowered  to 
highly significant  levels  (P< 0.001) compared to  its  reference range (Table-5). 
This decrease in serum albumin in preeclampsia could be the result of acute phase 
response plus albuminuria characteristic of preeclampsia.
Comparison of the lowered levels of serum albumin in preeclampsia and 
normal  pregnancy  reveals  a  significantly  lower  (P<0.05)  level  of  albumin  in 
preeclampsia  to  that  of  normal  pregnancy  (Table-6).  The  greater  lowering  of 
serum albumin in preeclampsia can be attributed to 2 factors namely acute phase 
response  and  albuminuria  contributing  to  the  lowering  in  the  above  condition 
against the single cause of plasma volume expansion in normal pregnancy.
When the level of albumin is compared with that of the minerals, it is seen 
that zinc and copper have a positive significant correlation with albumin (Table-7 
and Table-9), while copper has a negative significant correlation with it (Table-8).
Among  the  minerals  evaluated,  as  only  serum  zinc  and  copper  have 
revealed  statistically  significant  difference  in  their  decrease  and  increase 
respectively in normal pregnant and preeclamptic women, attempt has been made 
to  establish cut  off  levels  of  zinc  and copper  to  demarcate  preeclampsia  from 
normal pregnancy. For this purpose line graphs of zinc and copper by plotting 
their levels in 50 subjects each, of normal pregnancy and preeclampsia have been 
made in graphs 1 and 2 respectively.
TABLE – 10
   Serum zinc
S.No.
Cutoff 
values
(mg/L)
Sensitivity
(%)
Specificity
(%)
Positive 
predictive 
value
(%)
Negative 
predictive 
value
(%)
1. 0.35 38 82 67.8 57
2. 0.4 58 60 59 58.8
3. 0.42 68 50 57.6 61
4. 0.45 84 40 58.3 71.4
5. 0.48 92 30 56.7 79
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TABLE - 11
 Serum copper
S.No.
Cutoff 
values
(mg/L)
Sensitivity
(%)
Specificity
(%)
Positive 
predictive 
value
(%)
Negative 
predictive 
value (%)
 
GRAPH - 2
Serum copper (mg/L) in normal pregnant and preeclamptic women
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1. 2.4 80 42 58 67.7
2. 2.5 74 60 65 70
3. 2.6 66 70 68.75 67.3
4. 2.7 60 78 73 66
5. 2.8 52 88 81.25 64.7
6. 2.9 38 92 82.6 60
Table  -10  and  table  -11  reveal  the  calculated  sensitivity,  specificity, 
positive  predictive  value  and  negative  predictive  value  for  the  various  cut-off 
levels selected from the respective graphs for zinc and copper.  It is  clear from 
Table-10 that the cut off level of 0.42 mg/L for zinc, which has a sensitivity of 
68%,  specificity  of  50%,  positive  predictive  value  of  57.6%  and  negative 
predictive  value  of  61%,  can  be  the  most  appropriate  one  to  demarcate 
preeclampsia from normal pregnancy. Similarly from table-11, 2.5 mg/L of copper 
having a sensitivity of 74%, specificity of 60%, positive predictive value of 65% 
and negative predictive value of 70% is selected as the most suitable cut off level 
for the purpose.
The arrived appropriate  cut  off  values  of  serum zinc  and copper  of  the 
study, namely 0.42 mg/L and 2.5mg/L are also shown in the respective graphs. 
However since the above cut off values of both the minerals don’t have 100% 
sensitivity  or  specificity,  their  validity  is  rather  minimal  in  the  diagnosis  of 
preeclampsia.

CONCLUSION
From the study on serum zinc, copper, calcium and albumin conducted on a 
total of 150 subjects comprising of 50 non pregnant women, 50 normal pregnant 
and  50  preeclamptic  women,  the  following  inferences  were  arrived  at.  The 
conclusions  were  made  after  analysing  the  reference  range  obtained  from  the 
control group constituted by the 50 non pregnant women and on comparing the 
mean levels of the biochemical parameters of the other groups with the reference 
range and with one another.
I. In normal pregnant women
1. Serum zinc level is lower than in non pregnant women.
2. Serum copper level is higher than in non pregnant women.
3. Serum calcium level is lower than in  non pregnant women.
4. Serum albumin level is lower than in non pregnant women.
II. In preeclamptic women
1. Serum zinc level is lower than in non pregnant women and to that 
in normal pregnant women.
2. Serum copper level is higher than in non pregnant women and to 
that in normal pregnant women.
3. Serum calcium level is lower than in non pregnant women but 
similar to that in normal pregnant women.
4. Serum albumin level is lower than in non pregnant women and to 
that in normal pregnant women.
III. Serum zinc and calcium have a positive correlation with serum albumin 
while serum copper has a negative correlation.
IV. Most appropriate cut off level of zinc to demarcate preeclampsia is 0.42 
mg/L i.e. a level of 0.42 mg/L or below signifies preeclampsia.
V. Most suitable cut off level of copper to demarcate preeclampsia is 2.5 mg/L 
i.e. a level of 2.5 mg/L or above signifies preeclampsia.
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